Internal Medicine, Pulmonary Disease · Cleveland, OH
NPI
1861432213
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
9500 Euclid Ave
Cleveland, OH, 44195
Phone (216) 444-2200
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
724 services
Medicare patients, 2024
129
Average age 68
Drug cost, 2024
$646K
4,549 prescriptions
Company payments, 2025
$465
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Olufemi A Akindipe was code 99233 (hospital e&m - subsequent), 448 times for 55 patients. In total Olufemi A Akindipe billed 724 services in 9 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 448 | 55 | $89.21 | $40K |
| 99215 Office E&M - Established | Facility | 241 | 84 | $102.12 | $25K |
By year: 2022 $61K for 683 services; 2023 $70K for 740 services; 2024 $67K for 724 services.
Medicare prescription drug claims, 2024
In 2024, the drug Olufemi A Akindipe prescribed most often to Medicare patients was Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim), with 523 prescriptions and refills. In total Olufemi A Akindipe wrote 4,549 Medicare prescriptions that cost $646K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 523 | 1,038 | 127 | $2,095 |
| Azithromycin Generic | 445 | 937 | 112 | $7,136 |
| Prednisone Generic | 342 | 746 | 101 | $2,059 |
| Pantoprazole Sodium Generic | 305 | 681 | 78 | $4,222 |
| Atorvastatin Calcium Generic | 267 | 625 | 77 | $1,856 |
| Tacrolimus Generic | 226 | 480 | 57 | $49K |
| Metoprolol Tartrate Generic | 193 | 423 | 44 | $1,148 |
| Montelukast Sodium Generic | 191 | 445 | 49 | $1,632 |
| Valganciclovir Hcl Generic | 175 | 302 | 47 | $53K |
| Amlodipine Besylate Generic | 116 | 245 | 26 | $309 |
| Tamsulosin Hcl Generic | 75 | 128 | 14 | $1,002 |
| Mycophenolate Mofetil Generic | 74 | 153 | 29 | $4,246 |
| Rosuvastatin Calcium Generic | 71 | 179 | 22 | $619 |
| Gabapentin Generic | 55 | 92 | 14 | $265 |
| Omeprazole Generic | 55 | 161 | 17 | $1,178 |
Brand drugs: 258 claims; generic drugs: 4,251 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Olufemi A Akindipe $465 ($465 in general payments such as food, travel and fees) from 3 companies. The largest payer was Paragonix Technologies, Inc. with $350.
| Company | Payments | Amount |
|---|---|---|
| Paragonix Technologies, Inc. | 1 | $350 |
| Kamada Ltd. KMDA | 1 | $69.34 |
| Zambon USA Ltd. | 1 | $46.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.